Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
HMPL-306 by Hutchison MediPharma for Myelodysplastic Syndrome: Likelihood of Approval
HMPL-306 is under clinical development by Hutchison MediPharma and currently in Phase I for Myelodysplastic Syndrome. According to GlobalData, Phase...
Data Insights
HMPL-306 by Hutchison MediPharma for Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia): Likelihood of Approval
HMPL-306 is under clinical development by Hutchison MediPharma and currently in Phase I for Acute Myelocytic Leukemia (AML, Acute Myeloblastic...